MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-31-2025
Illumina ROA Ratio 2011-2025 | ILMN
Annual ROA Ratio Illumina
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19.4 | -11.48 | 5.01 | 8.65 | - | 13.7 | 11.87 | 10.81 | 12.52 | - | 10.58 | 4.15 | 3.94 | 6.79 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.7 | -19.4 | 4.76 |
Quarterly ROA Ratio Illumina
| 2025-Q3 | 2025-Q2 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -59.09 | -62.78 | -35.93 | -35.91 | -4.35 | -6.56 | -8.04 | -7.5 | 0.49 | 2.59 | 8.19 | 9.3 | 8.33 | 8.65 | 8.98 | 7.35 | 10.62 | 11.4 | 12.98 | 13.7 | 13.45 | 13.11 | 12.07 | 11.87 | 10.15 | 10.39 | 9.82 | 13.81 | 15.35 | 15.3 | 15.88 | 11.27 | 11.6 | 11.71 | 11.46 | 9.83 | 14.42 | 14.06 | 12.69 | 10.58 | 8.66 | 6.9 | 6.69 | 4.15 | 4.28 | 4.4 | 4.13 | 5.89 | 5.18 | 4.96 | 5.41 | 5.52 | 0.94 | 1.36 | 1.14 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.88 | -62.78 | 3.65 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 16.82 | -0.18 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 16.38 | 3.97 % | $ 170 M |  China |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.6 | -1.23 % | $ 2.03 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
3.43 | $ 39.39 | 1.97 % | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
5.03 | $ 228.73 | 0.98 % | $ 167 B | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 11.97 | 0.67 % | $ 340 M | Israel |
 |
DexCom
DXCM
|
8.64 | $ 67.19 | 0.34 % | $ 25.9 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.46 | -0.04 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 27.23 | 0.31 % | $ 823 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 20.72 | 0.78 % | $ 1.11 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 105.02 | -0.22 % | $ 4.14 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
-58.14 | $ 3.41 | -4.75 % | $ 109 K | USA |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 0.33 | -3.34 % | $ 9.68 M | USA |
 |
Quidel Corporation
QDEL
|
43.3 | $ 28.72 | -0.28 % | $ 1.21 B | USA |
 |
Guardant Health
GH
|
-29.37 | $ 103.82 | 1.72 % | $ 12.7 B | USA |
 |
IQVIA Holdings
IQV
|
5.1 | $ 223.38 | 0.52 % | $ 40.5 B | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
0.29 | $ 197.73 | 2.46 % | $ 10.2 B | USA |
 |
Quotient Limited
QTNT
|
-50.51 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 184.0 | 0.82 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 7.85 | - | $ 1.02 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 264.75 | 0.22 % | $ 22.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 187.27 | 0.37 % | $ 15.4 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
26.96 | $ 707.12 | 0.41 % | $ 58.3 B | USA |
 |
Lantheus Holdings
LNTH
|
15.78 | $ 66.85 | 0.35 % | $ 4.63 B | USA |
 |
Agilent Technologies
A
|
11.3 | $ 140.96 | 0.93 % | $ 42.9 B | USA |
 |
Mettler-Toledo International
MTD
|
26.64 | $ 1 405.6 | 0.84 % | $ 29.8 B | Schweiz |
 |
Myriad Genetics
MYGN
|
-12.39 | $ 7.22 | 0.14 % | $ 654 M | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.53 | -1.94 % | $ 5.81 M | USA |
 |
Bioventus
BVS
|
-19.27 | $ 7.64 | 1.13 % | $ 479 M | USA |
 |
NeoGenomics
NEO
|
-4.81 | $ 11.87 | 0.16 % | $ 1.5 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 6.82 | -0.66 % | $ 1.48 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | Israel |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |